Newsletter registration

By using our website, you are agreeing to cookies being stored and Google Analytics being used on your device in order to offer the best possible service. You can find more information on thishere.
Austria.
Where Great Emphasis is Put on Research.

Targeted inhibitors help against cancer – removal is harmful

"There are an increasing number of outbreaks of cancer, especially blood cancer, in which the hyperactivity of Tyk2 is the cause“, explained Mathias Müller of the Institute of Animal Breeding and Genetics at the University of Veterinary Medicine in Vienna. The signal conveyors can also trigger excessive immune reactions.

For this reason, substances are being developed which inhibit the previously known function of Tyk2 (or "kinase"). Signals are transmitted by attaching a “flag” (phosphate residue) to other proteins. Such medicines would be helpful in the fight against cancer and inflammation-related illnesses, the researchers say.

However, complications could arise in light of the fact that Tyk2 makes a considerable contribution to the maturing and activation of “natural killer cells”.  

In fact, mice in which completely lacked Tyk2 had killer cells which were baldy prepared, and could no longer control cancer growth. However, in animals in which Tyk2 was present but its kinase activity was inactivated, cancer growth was strongly suppressed and the natural killer cells retained their ability to effectively kill the cancer cells.

"Medicines aiming to inhibit kinase activity do not damage the work of the immune system“, explained Birgit Strobl of the Department for Molecular Genetics at the University of Veterinary Medicine in Vienna. Instead, they are more promising for cancer therapy than was originally thought. 

Share on Facebook Share on Facebook Share on Twitter Share on Twitter Share on Linkedin Share on Linkedin

Testimonials

Events

Meet us at events, seminars and trade shows - worldwide.

  • Standortseminar

    14.11.2018, Budapest, Hungary

  • Doing business in Austria

    20.11.2018, Žilina, Slovakia

Austria Map

Find the perfect location for your company

Vienna is the driving force for innovations in our company,
and one of the growth drivers.

Ottobock Austria

Logo
More testimonials

news from the business location Austria

Med University of Graz: New center for metabolism research

The kick-off for the Integrative Metabolism Research Center at the Medical University of Graz took place.

Startup Hotspot Austria

The Austrian government expects its Land of Founders strategy to enhance the entrepreneurial spirit and the courage to set up companies. The objective is to transform Austria into the most founder-friendly country in Europe. The initiatives have already borne fruit. The startup scene in Austria has been experiencing a strong boom over years now.

More news All blog posts